Freenome

Outpacing cancer starts with early detection

Freenome is an artificial intelligence company in South San Francisco, United States, founded in 2014. It has raised $554.0M across 2 rounds, most recently a $254.0M Series E in February 2024.

Employees
501–1000
Founded
2014
Business Model
B2B
Total Funding
$554.0M
Last Round
$254.0M Series EFeb 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 12 investors for this company. to use credits for reveals, or explore the API.

About

Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. Founded in 2014 and headquartered in Brisbane, California, Freenome uses a multiomics platform that analyzes genomic, epigenomic, and proteomic biomarkers—including tumor-derived cell-free DNA—combined with machine learning to produce actionable cancer screening results from a standard blood draw. The company's lead program targets colorectal cancer (PREEMPT CRC Study) with additional programs in lung and other cancers. In 2025, Freenome entered an exclusive license agreement with Exact Sciences for its colorectal cancer blood test and announced a $330M SPAC merger to go public.

Funding History

Data from Indexed.vcUpdated
Series ESeries EFeb 2024
$254.0M

1 more funding event

  • Series D20215 investors

Funding: Series D through Series E. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×3
  • Backend ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Freenome on Indexed.vc
<a href="https://indexed.vc/companies/freenome"><img src="https://indexed.vc/api/badge/company/freenome" alt="Freenome on Indexed.vc" width="260" height="76" /></a>